Boyd Steven
SEC CIK 1706140 · EDGAR
BoughtSold
Most active insiders at AVTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sullivan Christopher Ryan | CFO | — | $3.72M |
| 2 | Doyle Mittie | Chief Medical Off | — | $2.98M |
| 3 | VARKI PAUL | CLO | — | $1.51M |
| 4 | Goldman Jonathan | Dir | — | $163.0K |
| 5 | Chan Mitchell | Dir | — | $72.5K |
| 6 | Riley Jennifer | Chief Strategy Off | — | $52.0K |
| 7 | Truex Samantha | Dir | — | — |
| 8 | KANTOFF AARON | Dir | — | — |
| 9 | NEIL GARRY ARTHUR | CEO, Dir | — | — |
| 10 | KAPLAN GILLA | Dir | — | — |
Boyd Steven made no open-market trades at AVTX in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-03-07 | 2022-03-03+ | AVTX | Avalo Therapeutics, Inc. | Boyd Steven | Dir, 10% | P - Purchase | $0.6755 | +510.0K | 46.89M | +1% | +$344.5K |
| MI | 2022-02-22 | 2022-02-17+ | AVTX | Avalo Therapeutics, Inc. | Boyd Steven | Dir, 10% | P - Purchase | $0.8056 | +288.0K | 46.62M | +0.6% | +$232.0K |
| MI | 2022-01-14 | 2022-01-12+ | AVTX | Avalo Therapeutics, Inc. | Boyd Steven | Dir, 10% | P - Purchase | $0.992 | +455.0K | 46.10M | +1.0% | +$451.3K |
| MI | 2021-08-18 | 2021-08-16+ | AVTX | Avalo Therapeutics, Inc. | Boyd Steven | Dir, 10% | P - Purchase | $2.76 | +50.0K | 39.30M | +0.1% | +$138.1K |
| DMI | 2021-07-29 | 2021-07-27+ | KPRX | KIORA PHARMACEUTICALS INC | Boyd Steven | Dir, 10% | S - Sale | $4.61 | -3.15M | 4.13M | -43% | -$14.54M |
| DI | 2021-07-29 | 2021-07-27 | KPRX | KIORA PHARMACEUTICALS INC | Boyd Steven | Dir, 10% | C - Cnv Deriv | $4.80 | +852.5K | 4.20M | +25% | +$4.09M |
Purchase Sale Sale after option exercise All abbreviations